ANIP - ANI Pharmaceuticals Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call Transcript

ANI Pharmaceuticals, Inc. (ANIP) Q3 2020 Results Earnings Conference Call November 5, 2020, 10:30 AM ET Company Participants Lisa Wilson - In-Site Communications, IR Nikhil Lalwani - President and CEO Stephen Carey - Chief Financial Officer Conference Call Participants Dana Flanders - Guggenheim Elliot Wilbur - Raymond James Brandon Folkes - Cantor Fitzgerald Presentation Operator Good morning. And welcome to today’s program. My name is Nicole, and I will be your conference operator. At this time, I would like to welcome everyone to the ANI Pharmaceuticals Third Quarter 2020 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period. [Operator Instructions] As a reminder, this call is being recorded today, November 5, 2020. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for ANI Pharmaceuticals. Please go

For further details see:

ANI Pharmaceuticals, Inc.'s (ANIP) CEO Nikhil Lalwani on Q3 2020 Results - Earnings Call Transcript